Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma ProgressionJoão Conde, Gonçalo J. L. Bernardes, Marta C. Marques et al.|ACS Central Science|2021Cited by 63
A Phase 2 Study of Neo-adjuvant Metformin and Temozolomide followed by Hypofractionated Accelerated RadioTherapy (HART) with Concomitant and Adjuvant Metformin and Temozolomide (TMZ) in Patients with GlioblastomaGeorge Shenouda, Bassam Abdulkarim, Luís Souhami et al.|International Journal of Radiation Oncology*Biology*Physics|2020Cited by 7
A Phase 2 Trial of Neoadjuvant Temozolomide (TMZ) Followed By Accelerated Hypofractionated Radiation Therapy (AHRT) and TMZ Followed By Adjuvant TMZ in Patients with Newly Diagnosed Glioblastoma (GBM): Long Term Survival and Toxicity AnalysisGeorge Shenouda, Bassam Abdulkarim, Kevin Petrecca et al.|International Journal of Radiation Oncology*Biology*Physics|2018Cited by 2